Variant report
Variant | esv4311 |
---|---|
Chromosome Location | chr2:134544204-134544783 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs114084830 | chr2:134544209-134544210 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs370679176 | chr2:134544290-134544291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs202243069 | chr2:134544292-134544293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs199886965 | chr2:134544293-134544294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs11689967 | chr2:134544296-134544297 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs113001069 | chr2:134544298-134544299 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541862642 | chr2:134544301-134544302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563659639 | chr2:134544302-134544303 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs530802925 | chr2:134544306-134544307 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs552499485 | chr2:134544339-134544340 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570789179 | chr2:134544373-134544374 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528697014 | chr2:134544379-134544380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs546759548 | chr2:134544381-134544382 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552509864 | chr2:134544389-134544390 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs186061628 | chr2:134544390-134544391 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs12691844 | chr2:134544430-134544431 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369845832 | chr2:134544442-134544443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs28456146 | chr2:134544588-134544589 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs200295495 | chr2:134544606-134544607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs13010074 | chr2:134544607-134544608 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs111896547 | chr2:134544610-134544611 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535490474 | chr2:134544681-134544682 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564308256 | chr2:134544698-134544699 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs556769494 | chr2:134544711-134544712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs76684582 | chr2:134544772-134544773 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565015634 | chr2:134544773-134544774 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 17621639 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Breast cancer | 21509527 | CNVD |
Mental retardation | 17124404 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Neuroticism | 17667963 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:134535400-134544600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr2:134538200-134547600 | Weak transcription | Fetal Heart | heart |
3 | chr2:134542600-134545800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr2:134542800-134544600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr2:134542800-134547600 | Weak transcription | HUVEC | blood vessel |
6 | chr2:134544000-134549400 | Enhancers | Osteobl | bone |
7 | chr2:134544600-134545000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr2:134544600-134546600 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr2:134544600-134546600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
10 | chr2:134544600-134546800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr2:134544600-134549600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr2:134544600-134549800 | Enhancers | NHDF-Ad | bronchial |